SCHEMBL6636865

SCHEMBL6636865

[c]1cccc(-c2ccccc2)c1CNC1CCC1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
RAB9A P51151 1/20 0.43
SLC6A2 P23975 1/20 0.42
SLC6A4 P31645 1/20 0.42
SLC6A3 Q01959 1/20 0.42
CD274 Q9NZQ7 6/20 0.41
GAA P10253 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
NPSR1 Q6W5P4 2/20 0.38
LMNA P02545 2/20 0.38
ALDH1A1 P00352 2/20 0.38
OPRM1 P35372 1/20 0.38
OPRK1 P41145 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GRIN2B Q13224 2/20 0.36
GLA P06280 1/20 0.36
HTT P42858 1/20 0.36
KCNH2 Q12809 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6640137 0.97 KMT2A (0.43) MEN1KMT2ARAB9ASLC6A2SLC6A4
SCHEMBL21408620 0.94 MEN1 (0.49) MEN1KMT2ARAB9ASLC6A2SLC6A4
SCHEMBL6329476 0.84 ALDH1A1 (0.49) ALDH1A1GRIN2BKCNH2
SCHEMBL6324148 0.83 KDM4E (0.39) CD274HRH3NPSR1ALDH1A1GRIN2B
SCHEMBL6322030 0.81 ALDH1A1 (0.52) GAAALDH1A1GRIN2BKCNH2
SCHEMBL6331308 0.81 KDM4E (0.42) CD274HRH3NPSR1ALDH1A1OPRM1
SCHEMBL6322714 0.80 KDM4E (0.38) CD274GAAHRH3NPSR1ALDH1A1
SCHEMBL6328543 0.80 GPR39 (0.39) GAANPSR1ALDH1A1KCNH2
SCHEMBL6324190 0.77 KDM4E (0.40) GAAHRH3NPSR1ALDH1A1GLA
SCHEMBL6331061 0.77 GPR39 (0.41) KMT2AGAANPSR1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140871-A4 THROMBIN OR FACTOR XA INHIBITORS BRISTOL MYERS SQUIBB PHARMA CO (US) 2004-05-06 EP disclosed
EP-1140941-A1 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS Du Pont Pharmaceuticals Company (US) 2001-10-10 EP disclosed
EP-1140871-A1 THROMBIN OR FACTOR XA INHIBITORS Du Pont Pharmaceuticals Company (US) 2001-10-10 EP disclosed
WO-2000039108-A1 THROMBIN OR FACTOR XA INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 2000-07-06 WO disclosed
WO-2000039131-A1 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 2000-07-06 WO disclosed